header
Image from OpenLibrary

Detection of interleukin-2 gene polymorphisms in Egyptian Non-hodgkin lymphoma patients / Ekhlass Talaat Mohammed ; Supervised Somaia Abdelrahman Mousa , Manal Mohamed Makhlouf , Hamdi Mohamed Zawam

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Ekhlass Talaat Mohammed , 2016Description: 197 P. : facsimiles ; 25cmOther title:
  • دراسة التعدد الشكلى لجين الأنترلوكن - 2 فى المرضى المصريين المصابين بسرطان الغدد الليمفاوية الغير هودجكين [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology Summary: Interleukin 2 (IL-2) plays a central role in the activation of T cell-mediated immune responses and amplification of the lymphocyte responses in vivo. It promotes natural killer (NK) cell expansion and enhances intrinsic NK cell cytotoxicity. Two polymorphisms, -330T/G and+114T/G, have been identified in the IL-2 gene and are associated with various diseases and cancers. The aim of the study is to study the expression and to assess the impact of genetic polymorphisms of IL-2 on the susceptibility and prognosis of non-Hodgkin's lymphoma (NHL). Sixty patients with NHL as well as 60 age and sex matched healthy control subjects are included in this study. IL-2-330 T/G and+114 T/G genotypes were determined by PCR-RFLP. Our study revealed that both IL-2-330 T/G and+114 T/G gene polymorphisms are associated with increased risk of developing NHL with OR=3.609 (95% CI=1.527-8.417) and 4.142 (95% CI=1.637-10.538) respectively. Also, they increase the risk of bad outcome with OR=17.300 (95% CI=3.392-87.725) and 10.424 (95% CI=1.870-58.413) respectively. Moreover, combined presence of both polymorphisms is associated with about 6 folds increased risk of developing NHL. In conclusion, IL-2-330 T/G and +114 T/G gene polymorphisms could be involved in the pathophysiology and development of NHL. They may be useful as predictive molecular markers for prognosis and disease outcome in NHL patients
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.M.Sc.2016.Ek.D (Browse shelf(Opens below)) Not for loan 01010110071354000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.M.Sc.2016.Ek.D (Browse shelf(Opens below)) 71354.CD Not for loan 01020110071354000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology

Interleukin 2 (IL-2) plays a central role in the activation of T cell-mediated immune responses and amplification of the lymphocyte responses in vivo. It promotes natural killer (NK) cell expansion and enhances intrinsic NK cell cytotoxicity. Two polymorphisms, -330T/G and+114T/G, have been identified in the IL-2 gene and are associated with various diseases and cancers. The aim of the study is to study the expression and to assess the impact of genetic polymorphisms of IL-2 on the susceptibility and prognosis of non-Hodgkin's lymphoma (NHL). Sixty patients with NHL as well as 60 age and sex matched healthy control subjects are included in this study. IL-2-330 T/G and+114 T/G genotypes were determined by PCR-RFLP. Our study revealed that both IL-2-330 T/G and+114 T/G gene polymorphisms are associated with increased risk of developing NHL with OR=3.609 (95% CI=1.527-8.417) and 4.142 (95% CI=1.637-10.538) respectively. Also, they increase the risk of bad outcome with OR=17.300 (95% CI=3.392-87.725) and 10.424 (95% CI=1.870-58.413) respectively. Moreover, combined presence of both polymorphisms is associated with about 6 folds increased risk of developing NHL. In conclusion, IL-2-330 T/G and +114 T/G gene polymorphisms could be involved in the pathophysiology and development of NHL. They may be useful as predictive molecular markers for prognosis and disease outcome in NHL patients

Issued also as CD

There are no comments on this title.

to post a comment.